Results 201 to 208 of about 13,154 (208)

Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

Trends in Pharmacological Sciences, 1998
exaly  

HMG-CoA Reductase Inhibitors for Hypercholesterolemia

New England Journal of Medicine, 1988
exaly  

Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors

Pharmacological Research, 1990
exaly  

Purification and properties of two native, high-molecular-weight hydroxymethylglutaryl-CoA reductase phosphatases

Lipids and Lipid Metabolism, 1983
exaly  

Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors

1993
exaly  

On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors

Experimental Eye Research, 1990
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

The Cochrane Library
Jonathan Craig, David W Johnson, Vlado Perkovic   +2 more
exaly